Crude Oil (CL)

La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Colgate-Palmolive a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Colgate-Palmolive..

Colgate-Palmolive (NYSE:CL) Azioni, Catena delle Opzioni

COLGATE-PALMOLIVE CO

Colgate-Palmolive

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

Jim Cramer

Equities

Markets

ABBV

L&#39;analisi sulle nuove dinamiche di mercato evidenzia le sfide per gli investitori tra sicurezza, volatilità e strategie di rendimento.

Obbligazioni vs. azioni: Jim Cramer spiega dove sono i rendimenti migliori

The Coca-Cola Co.

Analyst Color

Analyst Ratings

Trading Ideas

Analisi BofA: quali aziende alimentari, di bevande e tabacco potrebbero performare al meglio in un contesto economico incerto.

Recessione in arrivo? Queste aziende sono pronte a resistere alle turbolenze

Large Cap

News

General

Nuova mossa nel mercato degli animali domestici. Scopri la strategia dietro questa acquisizione e come cambierà il settore.

Colgate-Palmolive investe nel pet food: ecco di chi si tratta

Looking into the current session, Colgate-Palmolive Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) shares are trading at $91.90, after a 1.13% increase. Moreover, over the past month, the stock spiked by 4.57%, but in the past year, fell by 1.43%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1749571223_0_0.png" alt="Past Year Chart" />

<h3>How Does Colgate-Palmolive P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 24.72 in the Household Products industry, Colgate-Palmolive Inc. has a higher P/E ratio of 25.74. Shareholders might be inclined to think that Colgate-Palmolive Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749571223_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: Colgate-Palmolive

No one likes a flip-flopper, whether in politics or stocks. When a stock can't make up its mind on a direction or trend, it can drive investors to abandon their positions in search of greener pastures.&nbsp;
This can create headaches in other areas, such as tax bills, trading fees, and overtrading, which can all be very costly. If you believe in a company&#8217;s long-term prospects but think in the short term that the stock will keep going sideways, there&#8217;s a better strategy than selling.
There&#8217;s a trading strategy that can let you collect income while you wait for the stock to grow to its full potential.
The strategy in question &#8211; covered calls &#8211; is used to earn income from a range-bound asset by selling a call option on a stock you already own. In this trade, you would sell a call option with a strike price slightly above the stock's current market price and collect the upfront premium. Your obligation to the option buyer is "covered" by the 100 shares you already own. If the strike price is reached and the call is exercised, you deliver 100 shares to the buyer and retain the premium.
However, if the call expires without hitting the strike, you keep the stock and pocket the premium as a profit. The upside is limited, but your downside risk is protected by collecting the premium and owning the stock.
A covered call is a neutral strategy, so your max profit is limited to the option premium. If the stock price increases too much, the option buyer will exercise the contract and claim the shares you hold at the strike price. And if the stock declines, the income from the option premium offsets some of your losses.
Today, we'll examine five stocks exhibiting range-bound behavior that could be suitable candidates for covered calls over the next few months. If you own any of the companies listed below, consider whether a covered call strategy aligns with your investment goals and risk tolerance.
<h2 class="wp-block-heading">JM Smucker Co. </h2>
JM Smucker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) makes popular snack treats and coffee, such as Uncrustables, Folgers, Carnation, and JIF, along with pet food brands like Meow Mix and Milk-Bone. The company has had uneven revenue over the last few years, and profit margins have sagged from the consistent 7-9% figures produced from 2021 to 2023.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXdOLILELt0easPJVO3FPlgkXTVdp87VMIYzaJFJF9u-qW7TwyKSBxEC56eE0xgruqTv_xEpxJz2ZHrYcHR9jdqwlsv4F7qRPe8Rfdf4gOKePiGVISfwQxXNLkoDVQq_wXgr9qrg7g?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
The stock has struggled as well, trading in a downtrending range for the better part of the last 18 months. While revenue growth has been spotty, the company appeals to income investment thanks to a 3.8% yield and 27 years of consecutive payout increases. On the daily chart, the RSI shows that the range-bound trading is likely to continue, making SJM a strong covered call candidate. The call option strike price should be set above the upper trendline on the chart, and investors can collect both dividend income and option premium. 
<h2 class="wp-block-heading">The Fed's About To Move The Market—Here's How Chris Capre Is Trading It</h2>
On June 11 at 6 PM ET, Chris Capre is going live to break down how he's preparing for the next Fed decision—before it hits and after the market reacts. You'll get his full options strategy, including pre-FOMC setups, post-reaction frameworks, and the tickers he's targeting for fast-moving trades. Secure your spot for free right <a href="https://events2.benzinga.com/chris-capre-webinar-wed-june11-2025/?utm_campaign=webinar061125&amp;utm_adType=RD051025&amp;utm_ad=061125">HERE</a>.
<h2 class="wp-block-heading">Ford Motor Co. </h2>
It's been a rough few years for Ford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>). The stock made new all-time highs during the 2021 bull market but lagged behind during the recovery from the 2022 bear market. The stock has been range-bound since mid-2022, trading between $9 and $15 for the better part of three years.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXePqqBCpRXN0Y7hol45T9gqw7XXm8KACWYRLlW0CH-cS_hn7tqu8nrNhXAr4vK7tfqVD4OrjgFJTTTgVvcL6znjpHTdQMJ3zHPbpKPTgcHzUMLQiMyxMsLnhG0ES4cUu3vif0AO8A?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
Ford shares could continue trading in this range even longer as the company's electrification goals will take years. Tariffs could also hit the Big Three automakers hard, although Ford has more domestic production than competitors like GM. With a Price-to-Earnings ratio under nine and a dividend yield over 7%, the stock is attractive to value investors, but it&#8217;s hard to get overly bullish on a stock facing so many potential headwinds. Ford is currently trading near the lower bound of its range, which means less premium collected on the call option, but also a slimmer chance of the stock reaching the strike price (which should be set around the $15 resistance level). 
<h2 class="wp-block-heading">Colgate-Palmolive Co. </h2>
Consumer staples companies like Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) make decent covered call candidates since they often have thin margins, steady demand, and low beta stocks. In other words, they don&#8217;t move much. However, CL shares make a different type of candidate as the stock's range has been narrowing in a wedge pattern, which could signal a consolidation of capital preparing to alter the current trend.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcieA8vY92exaX52Nb2uad0_5EgocO70FInhRxzV0KJ0rw9xtSkfiqxuuADK5dtgMn18SaXGbhjc6zW4bJe8NBOx1DVS9OEinfNl2Zo1713WoAYJC0jAbUE0orMznT72lx3lKJz1w?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
However, CL's wedge still has a wide range, and the stock is currently bumping up against the upper bound. Here's why CL is a good covered call candidate: if the stock fails to break above the trendline, it indicates the trend breakout isn't imminent, and the premium collected from selling a call at this level will be hefty. If the stock does break through the trendline, the trade idea can (and should) be aborted.
<h2 class="wp-block-heading">Walt Disney Co. </h2>
Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) has seen its own share of highs and lows over the last few years. Like Ford, the company has failed to recapture its all-time highs from 2021 and lagged the S&amp;P 500 as stocks recovered in 2023 and 2024. However, the company is seeing a revival of its theme park businesses and profit margins have expanded for four consecutive quarters. 
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXfpLcfj-v5EFnOWJvyaEEQ5aNKnyEvirt8IlccF_nQdoDnAJ9EdSFYGKSa9g0VEe5tb8g-rqeXFF6WHvq19OUl2dnovK8t3RpyxGsHcWxH5HahnqQ6zgr2sK0qjMVVa3YKS-yU7?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
So why is Disney stuck in this long-term range? Despite revenue expansion, Disney+ subscriber growth is actually starting to decline, and the company continues to struggle to find direction for sports properties like ESPN. The stock hasn't traded above $123 per share since August 2022, and the current market price is right at the resistance level of the range. Despite gains of more than 20% this month, Disney could be tapped out, making it ideal for a covered call if you own it.
<h2 class="wp-block-heading">Allstate Corp. </h2>
Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) reached a new all-time high as recently as March, and placing a resistance trendline at an all-time high can be risky when trading. But this is the third time ALL shares have approached this level; the first two attempts failed to continue the momentum. The more attempts a stock makes to break a resistance level, the stronger that level becomes. A third failure could be bad news for shareholders.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcNOFR_urReKPRZbHDQTKSWlvvgPZF1ZItZ-wkaUsGvmm75gQ1zG5uaN-JyINkWUhiNwUHmiQieGeA474tsCbqu7k2TU-xexByziafPa-uECQablzgqQrLl17S1QHrlfIHc6hZcdw?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
A covered call can protect your investment should the stock fail to breach the $213 level again. If the stock does make a new all-time high, don't write the call; enjoy the profits you earn from owning it. But if it looks like the stock has once again failed to break through and trends lower, the premium collected from selling the call can help offset the retreat back to support.
Editorial content from our expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies, which are neither expressly nor impliedly approved or endorsed by Benzinga.
Photo: Shutterstock

Personal Finance

5 Best Stocks To Trade For Income

Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) unveiled a sweeping overhaul on Thursday at the 2025 Deutsche Bank Global Consumer <a target="_blank" href="https://d18rn0p25nwr6d.cloudfront.net/CIK-0000080424/995e4954-0a90-46da-8215-51b98f42f344.html" rel="noreferrer noopener">Conference</a>. It outlined a strategy to simplify operations and sharpen its focus on core growth areas.
The move is part of a broader effort to boost efficiency and enhance long-term value for shareholders.
The restructuring plan includes cost-cutting initiatives and the elimination of up to 7,000 roles, primarily targeting non-manufacturing functions.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45789179/top-3-consumer-stocks-youll-regret-missing-this-quarter." rel="noreferrer noopener">Top 3 Consumer Stocks You&#8217;ll Regret Missing This Quarter</a>
P&amp;G anticipates taking pre-tax charges ranging between $1 billion and $1.6 billion over the next two fiscal years, with about 25% of those being non-cash charges tied to asset write-downs.
Procter &amp; Gamble intends to streamline its portfolio by divesting underperforming brands and exiting select markets. It also plans to revamp its supply chain using automation and digital tools while reducing organizational layers to cut overhead and reinvest in brand development.
For <a target="_blank" href="https://www.benzinga.com/25/04/44984872/gillette-parent-procter-gamble-slides-on-q3-sales-decline-lowered-outlook" rel="noreferrer noopener">the third quarter</a>, the company&#8217;s organic revenue climbed 5%, driven mainly by pricing strategies. Net income grew 8% to $8.6 billion, while GAAP earnings per share reached $3.49. Core EPS rose 4% to $3.81, and free cash flow productivity remained above 100%.
P&amp;G expects flat all-in sales and 2% organic growth for fiscal 2025. It lowered adjusted EPS guidance and forecasted $200 million in headwinds from commodities and forex. Dividend and buyback plans remain unchanged.
Related: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45020318/what-is-the-tariff-risk-for-procter-gamble-analyst-calculates-trims-outlook" rel="noreferrer noopener">What Is The Tariff Risk For Procter &amp; Gamble? Analyst Calculates, Trims Outlook</a>
P&amp;G also flagged external risks, including inflation, currency volatility, and global geopolitical issues. Yet the company expressed confidence in its long-term growth outlook, pointing to rising e-commerce demand, ongoing innovation in premium offerings, and increased exposure to developing markets.
Related ETFs: Consumer Staples Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>), Vanguard Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VDC#NYSE">VDC</a>).
Price Action: PG shares are trading lower by 0.15% to $165.70 premarket at the last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/asia/25/06/45791216/citi-to-cut-3500-tech-jobs-in-china-in-global-restructuring-spree" target="_blank" rel="noreferrer noopener">Citi To Cut 3,500 Tech Jobs In China In Global Restructuring Spree</a></li>
</ul>
Photo via Shutterstock

Procter & Gamble To Eliminate 7,000 Roles, Divest Brands In New Restructuring Strategy

Jim Cramer thinks that the bond market now offers a clearer risk-reward trade-off than so-called "safety" stocks, warning that rising 10-year Treasury yields and a political "wild card" in Washington make even dividend stalwarts feel shaky.
What Happened: The 10-year Treasury yield's jump to its highest level in more than a month has tightened the spread between bond payouts and blue-chip dividends, dulling the appeal of AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) and Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), Cramer <a href="https://www.cnbc.com/2025/05/14/jim-cramer-explains-why-its-hard-to-own-usual-safety-stocks-here.html">told</a> CNBC&#8217;s &#8216;Mad Money&#8217; viewers on Wednesday.
"In a very uncertain tape for what <a href="https://www.benzinga.com/content/44809259/3-safe-dividend-stocks-as-investors-seek-to-reset-diversification">used to be called</a> ‘safety stocks,' I'd rather just own a piece of paper like the 10-year Treasury, where, if worst comes to worst, at least I get my money back," Cramer said.
Cramer flagged Robert F. Kennedy Jr., newly installed as Health and Human Services secretary, as an <a href="https://www.benzinga.com/markets/equities/24/11/42254495/trumps-hhs-pick-rfk-jr-has-a-long-history-of-challenging-global-health-policies">unpredictable force</a> who could clamp down on pharmaceutical pricing and food additives. "Investors don't know whether Kennedy will act in favor of the companies he's tasked with regulating," he cautioned.
See also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45426516/chuck-schumer-says-trump-is-letting-cartel-members-into-the-us-asks-how-much-memecoin-did-they-pay">Chuck Schumer Says Trump Is &#8216;Letting Cartel Members&#8217; Into The US, Asks How Much &#8216;Memecoin&#8217; Did They Pay</a>
What To Know: That uncertainty compounds existing headaches. Johnson &amp; Johnson is <a href="https://www.benzinga.com/general/biotech/25/04/44586129/us-judge-rejects-another-johnson-johnson-attempt-to-use-bankruptcy-for-talc-cancer-claims">still wrestling</a> with talc-related lawsuits that have already cost billions in settlements and reserves, a cloud Wall Street <a href="https://www.benzinga.com/25/04/44920880/expert-flags-never-before-observed-trio-falling-stocks-and-short-yields-bucking-rising-long-yields-nothing-is-normal-about-this">fears could grow</a> heavier if bond yields <a href="https://www.benzinga.com/25/05/45399783/gordon-johnson-warns-of-potential-liberation-day-20-as-30-year-treasury-yields-approach-5-amid-dollar-weakness?utm_source=chatgpt.com">keep luring</a> income-seekers away. AbbVie's rich dividend likewise looks less generous when a risk-free Treasury pays nearly the same rate with zero headline risk.
Consumer staples aren't immune either, says Cramer. Procter &amp; Gamble and Colgate boast recession-proof brands, yet their 2–3% yields no longer tower over Treasuries, and Cramer said "the yields may simply not be high enough to justify the risk."
Snack titan PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) and cereal maker General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) could also <a href="https://www.benzinga.com/government/regulations/24/11/42144709/kennedys-war-on-food-dyes-could-be-coming-to-your-breakfast-table">come under fire</a> if Kennedy pushes to restrict artificial colors and other additives, Cramer warned, asking rhetorically whether kids would still eat Lucky Charms without its rainbow marshmallows.
Why It Matters: For now, Cramer said he is "tempted to buy General Mills" on weakness, but fears Washington's next pitch more than the stock's upside.
Cramer also told "Mad Money" viewers that recession worries can be a buying opportunity, saying high-quality retailers look cheap so long as you don't think the economy will "fall off a cliff." Despite earlier warning, the sector was in the trade-war "blast radius," he now does have a <a href="https://www.benzinga.com/25/05/45416455/jim-cramer-says-these-retail-stocks-rl-gap-can-survive-a-market-correction">couple of clear favorites</a> to scoop up on any dip.
Benzinga Edge Stock Rankings indicate Johnson &amp; Johnson has a Momentum in the 47th percentile and Growth in the 63rd, how do other &#8220;safety&#8221; stocks rank in terms of these metrics? <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Check them out here</a>.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="442" height="282" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15010652/Screenshot-2025-05-15-at-14.06.33.png" alt="" class="wp-image-915950" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15010652/Screenshot-2025-05-15-at-14.06.33.png 442w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15010652/Screenshot-2025-05-15-at-14.06.33-300x191.png 300w" sizes="(max-width: 442px) 100vw, 442px" /></figure>
Photo courtesy: katz / Shutterstock.com
Read next: <a href="https://www.benzinga.com/general/travel/25/05/45427289/peter-schiff-warns-qatars-200-billion-boeing-deal-could-spike-us-inflation-interest-rates-says-treasury-sell-off-may-follow">Peter Schiff Warns Qatar&#8217;s $200 Billion Boeing Deal Could Spike US Inflation, Interest Rates — Says Treasury Sell-Off May Follow</a>

Jim Cramer Says Even 'Safety' Stocks Look Risky, Warns Of 'Wild Card' In Washington And Rising Treasury Yields As Reasons To Stay Away From Sure Bets

Colgate-Palmolive Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) posted better-than-expected first-quarter FY25 <a href="https://www.benzinga.com/quote/CL/earnings">earnings on Friday</a>.
The company&#8217;s first-quarter FY25 sales declined 3% year over year to $4.91 billion, beating the analyst consensus estimate of $4.86 billion. Non-GAAP EPS of $0.91 beat the consensus estimate of $0.86.
&#8220;As we look ahead, uncertainty and volatility in global markets, including the impact of tariffs, remain challenging. We are confident in our strategy and will continue to execute with focus and agility to mitigate these factors and achieve our revised 2025 financial targets,&#8221; said Chairman, President, and CEO Noel Wallace.
For FY25, Colgate said it expects net sales to be up in the low single digits, including a negative impact from foreign exchange in the low single digits. The company anticipates organic sales growth to be 2% to 4%.
Colgate shares fell 3% to trade at $91.08 on Monday.
These analysts made changes to their price targets on Colgate following earnings announcement.
<ul>
<li>JP Morgan analyst Andrea Teixeira maintained Colgate-Palmolive with an Overweight rating and raised the price target from $95 to $103.</li>
<li>Citigroup analyst Filippo Falorni maintained Colgate-Palmolive with a Buy and raised the price target from $103 to $108.</li>
</ul>
Considering buying CL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-1024x560.png" alt="" class="wp-image-891420" style="width:532px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200.png 1172w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/45038052/top-2-industrials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Industrials Stocks That May Fall Off A Cliff This Quarter</a></li>
</ul>

Earnings

Price Target

Colgate-Palmolive Analysts Increase Their Forecasts After Upbeat Results

Citigroup analyst Filippo Falorni maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Buy and raises the price target from $103 to $108.

Citigroup Maintains Buy on Colgate-Palmolive, Raises Price Target to $108

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Overweight and raises the price target from $95 to $103.

JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $103

After months of sluggish performance, cannabis stocks finally caught a break. Federal reform chatter—this time involving Donald Trump—helped fuel a rally across the sector. But even with this uptick, analysts are urging caution.
Beyond the markets, the global cannabis map keeps evolving: Portugal has quietly become Europe's biggest exporter, Spain banned HHC and Argentina passed a sweeping "anti-mafia" law raising concerns for patients and cannabis activists. Meanwhile, California cities slash taxes to save local stores and a cult rolling paper brand opened its factory doors to the public for the first time ever.
Let's dive in.
<h2 class="wp-block-heading">Politics And Policy</h2>
<h3 class="wp-block-heading">Trump Reportedly Pushing For SAFE Banking Reform</h3>
The AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) closed the week up 9.7% after reports that Trump is privately encouraging lawmakers to pass banking reform ahead of the 2026 midterms. Analysts say the rally is likely technical unless public support follows.
Read more on <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/45011379/why-cannabis-stocks-jumped-by-double-digits-and-why-analysts-say-dont-drink-the-kool-aid-in-one-gulp">Benzinga</a>
<h3 class="wp-block-heading">Argentina's New Anti-Mafia Law Raises Civil Rights Concerns</h3>
Passed last month, Argentina&#8217;s new law allows authorities to detain suspects, seize property and wiretap phones without judicial approval in designated zones. Experts fear the law could be used to target medical cannabis users and community organizations.
Read more on <a class="" href="https://elplanteo.com/ley-antimafia-argentina/">El Planteo</a>
<h3 class="wp-block-heading">Hungary Ramps Up Drug War Ahead of Elections</h3>
Hungary is pushing a constitutional amendment to criminalize drug use and give law enforcement broader powers. Critics say the government is using prohibitionist rhetoric to boost voter support.
Read more on <a class="" href="https://elplanteo.com/hungria-guerra-drogas/">El Planteo</a>
<h3 class="wp-block-heading">Spain Bans HHC And Other Semi-Synthetic Cannabinoids</h3>
Spain added HHC and several related compounds to its list of controlled substances, effectively banning their sale and distribution nationwide.
Read more on <a class="" href="https://elplanteo.com/espana-prohibe-hhc-cannabinoides/">El Planteo</a>
<h3 class="wp-block-heading">Portugal Nearly Triples Cannabis Exports</h3>
Portugal exported 32,558 kilos of cannabis in 2024, a 172% increase over the prior year. It now ranks as the largest cannabis exporter in Europe and second globally behind Canada.
Read more on <a class="" href="https://www.theportugalnews.com/news/2025-04-24/portugal-cannabis-exports-almost-triple/97136">The Portugal News</a>
<h2 class="wp-block-heading">Markets And Stocks</h2>
<h3 class="wp-block-heading">Body And Mind Sells Long Beach Dispensary For $856K</h3>
Body and Mind Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/BAMM#CSE">BAMM</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) is divesting its Long Beach location for $856,250. The company is shifting its focus to retail expansion in Illinois and New Jersey.
<h3 class="wp-block-heading">Green Market Report Closes Its Doors</h3>
Green Market Report, one of the few cannabis-focused financial news outlets, has shut down. Founder Debra Borchardt confirmed that Crain Communications, which acquired the site in 2022, decided to discontinue operations. All staff members have been laid off except veteran journalist John Schroyer, who will remain at Crain to cover cannabis and other sectors.
The closure is a major loss for the industry—and a stark reminder of how vulnerable cannabis media remains. With few specialized outlets left standing, supporting independent reporters and sector-specific journalism is more essential than ever. Generalist coverage often misses the nuance, science and community insight that cannabis reporting requires.
If you wonder how you can support your favorite media outlets and journalists, <a href="mailto:javierhasse@benzinga.com">email me</a>.
<h2 class="wp-block-heading">Culture And Commentary</h2>
<h3 class="wp-block-heading">Inside The RAW Factory: Where Iconic Papers Are Born</h3>
In a rare behind-the-scenes look, Benzinga visited RAW's Spanish production site in Benimarfull. Founder Josh Kesselman walked us through the machines, secrecy and craftsmanship behind the world's most famous rolling paper brand.
Read more on <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44992856/willy-wonka-of-weed-opens-the-doors-to-the-raw-factory-heres-what-we-saw">Benzinga</a>
Watch the <a href="https://www.youtube.com/watch?v=6TRFUO4_Yng">video</a> below:
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="The WILLY WONKA OF WEED Opened The Doors To The RAW Factory: Here's What We Saw" width="500" height="281" src="https://www.youtube.com/embed/6TRFUO4_Yng?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h2 class="wp-block-heading">Business And Brands</h2>
<h3 class="wp-block-heading">Curaleaf Debuts Anthem Pre-Roll Brand</h3>
Curaleaf Holdings, Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CURA#TSX">CURA</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) launched a new pre-roll brand, Anthem, now available in New York, New Jersey, Illinois, and Massachusetts. Additional state launches are planned for summer.
<h3 class="wp-block-heading">Wynk Expands Into Four More States</h3>
Hemp seltzer brand Wynk is now available in Kentucky, Arkansas, Alabama and Wisconsin—building on its presence in New Jersey, Texas and Florida. The company has secured major retail placements and distributor partnerships in each new state.
<h3 class="wp-block-heading">Humboldt Seed Co. Releases OG Triploid Autoflower Strain</h3>
Humboldt Seed Company launched an OG triploid autoflower strain boasting 30–34% THC and fast flowering times. It's non-GMO and bred for outdoor cultivators looking to match indoor potency and yield.
<h2 class="wp-block-heading">Industry And Infrastructure</h2>
<h3 class="wp-block-heading">Cresco Labs Opens $15M Cultivation Facility In Kentucky</h3>
Cresco Labs (CSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#CSE">CL</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) cut the ribbon on a $15.4 million facility in Winchester, KY. The site is expected to be operational by year-end and will support the state's newly launched medical cannabis program.
<h3 class="wp-block-heading">California Cities Slash Taxes As Stores Struggle</h3>
Cities across the Coachella Valley—including Desert Hot Springs and Palm Springs—are reducing cannabis taxes in response to widespread retail closures. Sonoma County followed suit, while San Diego and the state move in the opposite direction.
Read more on <a class="" href="https://www.sfgate.com/cannabis/article/california-cannabs-tax-rates-fall-20281817.php">SFGate</a>
<h2 class="wp-block-heading">Recommended Reads</h2>
<a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/24/carmelo-anthonys-cannabis-mission-comes-home-i-know-the-door-i-hold-open/">Carmelo Anthony's Cannabis Mission Comes Home: ‘I Know The Door I Hold Open'</a> NBA legend Carmelo Anthony opens up about cannabis advocacy, business ownership and legacy-building in New York.
<a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/22/is-america-missing-out-on-the-global-cannabis-boom/">Is America Missing Out On The Global Cannabis Boom?</a> As Europe, Latin America, Asia and Africa expand cannabis markets, U.S. inaction threatens its leadership position globally.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/45018519/how-local-opposition-threatens-long-islands-cannabis-market-and-what-that-means-for-investors">How Local Opposition Threatens Long Island&#8217;s Cannabis Market And What That Means For Investors</a> Local bans and delays are creating major hurdles for New York's cannabis rollout—especially in suburban strongholds.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44957196/these-are-the-cannabis-industrys-power-players-according-to-forbes">These Are The Cannabis Industry&#8217;s Power Players, According To Forbes</a> Forbes unveils its latest list of top cannabis executives, entrepreneurs and advocates shaping the industry's future.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44956994/145-years-later-zig-zag-gets-loud-about-weed-with-times-square-takeover">145 Years Later, Zig-Zag Gets Loud About Weed With Times Square Takeover</a> The iconic rolling paper brand embraces cannabis culture with a bold advertising splash in the heart of New York.
<a class="" href="https://www.benzinga.com/25/04/44934689/snoop-doggs-last-dance-is-cannabis-cinema-at-its-weirdestand-its-got-funkadelic-dad-rock-counterpart">Snoop Dogg&#8217;s &#8216;Last Dance&#8217; Is Cannabis Cinema At Its Weirdest—And There&#8217;s A Funkadelic &#8216;Dad Rock&#8217; Counterpart</a> Snoop Dogg releases a psychedelic music video tribute to cannabis culture.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44929611/why-pre-rolls-are-cannabis-most-profitable-format-from-california-to-canada">Why Pre-Rolls Are Cannabis&#8217; Most Profitable Format, From California To Canada</a> Pre-rolls are dominating retail shelves and margins, solidifying their status as the cannabis industry&#8217;s breakout category.
That's it for this week. See you next Friday with another roundup of what's shaping the cannabis world—on Wall Street, in Washington and around the globe.

Cannabis

Politics

BMMJ

CRLBF

CSE:BAMM

CSE:CL

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

MSOS

TSX:CURA

This Week In Cannabis: Trump's Reform Buzz Drives Stocks Up, RAW's Secret Factory, Global Shifts And More

Wall Street's three-day rally came to a pause on Friday, with major indices hovering near the flatline by midday in New York as caution returned amid mixed signals on <a href="https://www.benzinga.com/news/global/25/04/45004954/china-reportedly-begins-exempting-key-us-imports-from-tariffs-including-pharma-and-aerospace-parts">U.S.-China trade relations.</a>
President Donald Trump claimed to have held a phone call with President Xi Jinping, yet Chinese officials denied that any talks had taken place.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) extended its rally into a fourth consecutive session, notching its best weekly performance of the year with a 16% gain. On Thursday afternoon, Transportation Secretary Sean Duffy introduced a new regulatory framework for self-driving vehicles, saying it aimed to reduce bureaucratic hurdles and advance toward a unified national standard.
T-Mobile US Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NYSE">TMUS</a>) was the biggest laggard of the day, falling 11%, on track for its worst single-day loss since March 2020. This came despite better-than-expected earnings, as its core wireless business posted slower growth than analysts had projected.
Among sectors, consumer discretionary led gains, buoyed by Tesla's 8% gain, while materials underperformed.
In fixed income, Treasury yields declined for a fourth straight session, underscoring how critical Trump's early-week reassurance — that he would not dismiss Fed Chair Jerome Powell — was for bond market sentiment.
The yield on the 10-year Treasury note dropped 4 basis points to 4.27%, on course for its lowest close since April 8.
In commodities, gold slid 2%, oil held steady at $62 per barrel, and natural gas rose 1% to $3 per million British thermal units, snapping a 10-session losing streak.
In crypto markets, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rose 1.2% to $95,000.
<h2 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,250.90</td>
<td>+0.2%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,488.71</td>
<td>+0.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>39,908.60</td>
<td>-0.5%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,942.82</td>
<td colspan="2">-0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) flattened at $546.92.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) eased 0.5% to $399.23.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;fell 0.2% to $468.61.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.7% to $192.79.</li>
<li>The&nbsp;Consumer Discretionary&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 1.1%; the&nbsp;Materials Care&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) lagged, down 1.1%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
Stocks reacting to earnings report included:
<ul>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>): up 1.7%</li>
<li>T-Mobile US Inc.: down 10.9%</li>
<li>AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>): up 2.4%</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>): down 7.2%</li>
<li>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>): down 3.2%</li>
<li>Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>): down 11.0%</li>
<li>Republic Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>): down 0.2%</li>
<li>Digital Realty Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>): up 3.0%</li>
<li>HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>): down 5.2%</li>
<li>Charter Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>): up 10.3%</li>
<li>The Hartford Financial Services Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>): down 1.1%</li>
<li>Weyerhaeuser Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>): down 2.1%</li>
<li>Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>): up 1.1%</li>
<li>Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>): down 7.7%</li>
<li>LyondellBasell Industries N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>): up 0.0%</li>
<li>VeriSign Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>): up 9.1%</li>
<li>Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>): down 2.0%</li>
<li>Carrier Global Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>): down 0.5%</li>
<li>Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>): down 0.7%</li>
<li>Erie Indemnity Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIE#NASDAQ">ERIE</a>): down 11.8%</li>
<li>Principal Financial Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>): down 1.4%</li>
<li>Eastman Chemical Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>): down 6.0%</li>
<li>Healthpeak Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>): down 4.7%</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45009066/goldman-sachs-upgrades-charles-schwab-to-buy-one-of-the-best-earnings-growth-outlooks-analyst-says">Goldman Sachs Upgrades Charles Schwab To Buy: &#8216;One Of The Best Earnings Growth Outlooks,&#8217; Analyst Says</a></li>
</ul>
Photo: Shutterstock

Government

Macro Economic Events

Regulations

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

ETFs

$BTC

CARR

CHTR

SPDR Dow Jones Industrial Average ETF Trust

ERIE

GILD

GOOGL

INTC

TMUS

TSLA

VRSN

Select Sector SPDR-Consumer Discretionary

Wall Street Rally Pauses, Tesla Heads For Strongest Week In 6 Months: What's Driving Markets Friday?

Colgate-Palmolive Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) shares are <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45004176/colgate-announces-1st-quarter-2025-results" rel="noreferrer noopener">trading higher in premarket</a> on Friday after the first-quarter FY25 earnings report.
The company's <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45004176/colgate-announces-1st-quarter-2025-results" rel="noreferrer noopener">first-quarter FY25 sales</a> declined 3% year over year to $4.91 billion, beating the analyst consensus estimate of $4.86 billion.
Organic sales increased by 1.4%. Total Oral, Personal, and Home Care net sales increased&nbsp;by&nbsp;6.8% to $3.96 billion.
Non-GAAP EPS of $0.91 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus </a>estimate of $0.86.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/04/44977669/pepsico-ceo-warns-of-tariffs-led-increase-in-supply-chain-costs-cuts-annual-profit-outlook" rel="noreferrer noopener">PepsiCo CEO Warns Of Tariffs Led ‘Increase In Supply Chain Costs,' Cuts Annual Profit Outlook</a>
Colgate's gross profit was $2.98 billion, while the margin expanded 80 basis points to 60.8%. Selling, general and administrative expenses slipped 0.9% to $1.8 billion.
Operating margin expanded 120 basis points to 21.9%, and operating income increased 2.8% to $1.07 billion for the quarter.
As of March 31, the company had $1.11 billion in cash and equivalents, and its operating cash flow totaled $600 million.
"As we look ahead, uncertainty and volatility in global markets, including the impact of tariffs, remain challenging. We are confident in our strategy and will continue to execute with focus and agility to mitigate these factors and achieve our revised 2025 financial targets," said Chairman, President, and CEO Noel Wallace.
Outlook FY25: Colgate expects net sales to be up in the low single digits, including a negative impact from foreign exchange in the low single digits.
The company anticipates organic sales growth to be 2% to 4%.
The current outlook is better from the last quarter, where <a target="_blank" href="https://www.benzinga.com//node/43385529" rel="noreferrer noopener">it expected FY25 net sales</a> to be roughly flat, including a mid-single-digit negative impact from foreign exchange.
On a non-GAAP basis, the company expects gross profit margin and advertising to be roughly flat as a percentage of net sales and earnings per share to be up in the low single digits.
Price Action: CL shares traded higher by 1.19% at $93.80 in premarket session at the last check on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44996394/chipotle-battles-slumping-sales-but-honey-chicken-boosts-hope-say-analysts" target="_blank" rel="noreferrer noopener">Chipotle Battles Slumping Sales, Analyst Pin Hope On Honey Chicken</a></li>
</ul>
Photo by EDSON DE SOUZA NASCIMENTO via Shutterstock

Guidance

Colgate-Palmolive CEO Wallace Says 'Impact Of Tariffs Remain Challenging,' But Raises Annual Revenue Outlook Slightly

Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) .

Colgate-Palmolive expects FY 2025 Net sales to be up low single digits, including a low-single-digit negative impact from foreign exchange.

Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.86 by 5.81 percent. This is a 5.81 percent increase over earnings of $0.86 per share from the same period last year. The company reported quarterly sales of $4.91 billion which beat the analyst consensus estimate of $4.86 billion by 0.95 percent. This is a 3.04 percent decrease over sales of $5.07 billion the same period last year.

Earnings Beats

Colgate-Palmolive Q1 Adj. EPS $0.91 Beats $0.86 Estimate, Sales $4.91B Beat $4.86B Estimate

U.S. stock futures traded mixed on Friday after three consecutive days of gains, with S&amp;P 500 futures edging higher amid <a href="https://benzinga.com/analyst-ratings/analyst-color/25/04/44988781/wall-street-rally-extends-into-third-day-whats-driving-markets-thursday">rising earnings optimism</a> and signs of easing U.S.-China trade tensions.
The first quarter earnings report of Google-parent Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) topped estimates, adding to investor confidence following weeks of uncertainty.
Investors will be keeping an eye on AbbVie Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>),&nbsp;HCA Healthcare Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), and&nbsp;Aon PLC&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>), among several other corporate earnings that are set to be released on Friday. 
U.S. 10-Year Treasury yields stood at 4.3% and 2-Year Treasury yields at 3.80%. According to the CME Group&#8217;s FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a> predictions, there is a 95.3% chance of the Federal Reserve keeping interest rates unchanged during its next meeting in May.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.13%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>+0.20%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.22%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.48%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) dipped 0.19% and 0.37%, respectively, in Friday's premarket trading, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;17jsfbw&#x2A;_gcl_au&#x2A;MjA5Njc0MjY1My4xNzQwODM2NTUw&#x2A;_ga&#x2A;R1MxLjEuMTc0NDY0ODA3Mi4yLjAuMTc0NDY0ODA3NS4wLjAuMA..&#x2A;_ga_V7ZK73W7N0&#x2A;MTc0NTU3MTI2OS4xLjEuMTc0NTU3MTQ4My4wLjAuMA..">Benzinga Pro</a> data.
Cues From Last Session: 
The markets were buoyed by the strong performance of Alphabet and T-Mobile US Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>), but several others, such as Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) and PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>), fell short of estimates.
Economic data was largely mixed on Thursday, with the Initial Jobless Claims report at 220,000, against a forecast of 222,000, while Existing Home Sales came in at 4.03 million, falling short of the median forecast at 4.13 million.
All S&amp;P 500 sectors advanced on Thursday, barring consumer staples, which declined 0.88% owing to the lackluster earnings of PepsiCo and Procter &amp; Gamble during the day.
As of Thursday, the Nasdaq 100 was down 13.5% from its previous high of 22,222.61 points, the S&amp;P 500 was down 10.8% from a high of 6147.43 points, and finally, the Dow Jones Industrial Average was down 11% from its high of 45,073.63.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>2.74%</td>
<td>17,166.04</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>2.03%</td>
<td>5,484.77</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>1.23%</td>
<td>40,093.40</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2.00%</td>
<td>1,957.59</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts: 
Market analyst, Ryan Detrick, highlighted the fact that the S&amp;P 500 has risen by at least 1.5% for three trading days in a row, saying that, &#8220;This isn&#8217;t stuff you see in bear market rallies or short covering rallies.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The S&amp;P 500 is up at least 1.5% for three days in a row. This isn&#39;t stuff you see in bear market rallies or short covering rallies. You see this before times of strong performance. Higher 10 out of 10 times a year later and up 21.6% on average. <a href="https://t.co/kfvfNKq6IK">pic.twitter.com/kfvfNKq6IK</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1915608371840921812?ref_src=twsrc%5Etfw">April 25, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;You see this before times of strong performance,&#8221; he says, &#8220;higher 10 out of 10 times a year later and up 21.6% on average,&#8221; each time you see three consecutive daily gains of 1.5% or more in the S&amp;P 500.
Upcoming Economic Data:
Here&#8217;s what investors will be looking at on Friday,
<ul>
<li>The Consumer Sentiment (Final) report is set to be released at 10 AM Eastern Time on Friday.</li>
</ul>
Stocks In Focus:
<ul>
<li>AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) is up 2.40% in pre-market trade as it is set to report its earnings this morning, with analysts expecting earnings of $2.40 per share, on $12.9 billion in revenue. </li>
<li>HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) is down 0.43% pre-market and is set to report its earnings before the bell, with analysts expecting $5.75 per share, on $18.3 billion in revenue. </li>
<li>Aon PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) is set to report its earnings prior to the opening bell and is up 1.08% pre-market. Analysts expect earnings of $6.03 per share, on $4.8 billion in revenue. </li>
<li>Colgate-Palmolive Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) is up 0.18% in pre-market trade in anticipation of its first quarter earnings prior to the opening bell. Analysts expect the FMCG giant to post $0.86 per share in earnings, on $4.8 billion in revenue. </li>
<li>Charter Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) is down 4.8% in pre-market trade and is set to report its first quarter results before markets open. Analysts expect $8.59 per share in earnings and $13.7 billion in revenue.</li>
</ul>
Commodities, Gold And Global Equity Markets
Crude oil futures are trading down 0.68% in the early New York session on Friday, at $62.63 per barrel.
The U.S. Dollar Index (DXY) is up 0.37%, trading at 99.74, while gold spot prices continue to witness a pullback, trading at 3,299.63, down 1.08%.
Asian markets edged higher on Friday, with the Nikkei 225, Kospi, and Shenzhen ending the day in the green, along with Australia&#8217;s ASX 200. India&#8217;s Nifty 50 and the Sensex are ending the week down.
Image Via shutterstock

GOOG

US Stock Futures Mixed After Three-Day Winning Streak: Expert Dismisses Market Pessimism, Says 'This Isn't Stuff You See In Bear Market'

<h3>Companies Reporting Before The Bell</h3>
• Gentex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNTX#NASDAQ">GNTX</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $572.09 million. 
• Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) is estimated to report quarterly earnings at $2.76 per share on revenue of $811.53 million. 
• Phinia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHIN#NYSE">PHIN</a>) is estimated to report quarterly earnings at $1.00 per share on revenue of $814.11 million. 
• Virtus Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRTS#NYSE">VRTS</a>) is estimated to report quarterly earnings at $5.41 per share on revenue of $201.41 million. 
• Stellar Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEL#NYSE">STEL</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $105.66 million. 
• AutoNation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) is estimated to report quarterly earnings at $4.38 per share on revenue of $6.64 billion. 
• Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) is estimated to report quarterly earnings at $0.82 per share on revenue of $387.70 million. 
• Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) is projected to report quarterly earnings at $0.52 per share on revenue of $623.41 million. 
• Flagstar Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) is expected to report quarterly loss at $0.28 per share on revenue of $509.58 million. 
• Portland Gen Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POR#NYSE">POR</a>) is estimated to report quarterly earnings at $0.99 per share on revenue of $970.49 million. 
• AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) is likely to report quarterly earnings at $2.38 per share on revenue of $12.92 billion. 
• HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) is expected to report quarterly earnings at $5.76 per share on revenue of $18.26 billion. 
• Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) is projected to report quarterly earnings at $8.69 per share on revenue of $13.68 billion. 
• Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) is projected to report quarterly earnings at $0.74 per share on revenue of $8.60 billion. 
• Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) is expected to report quarterly loss at $0.72 per share on revenue of $31.33 billion. 
• Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) is projected to report quarterly earnings at $0.86 per share on revenue of $4.86 billion. 
• LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) is expected to report quarterly earnings at $0.43 per share on revenue of $7.46 billion. 
• Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) is expected to report quarterly earnings at $6.02 per share on revenue of $4.86 billion. 
• Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) is expected to report quarterly earnings at $2.54 per share on revenue of $43.36 billion. 
• Addex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) is expected to report earnings for its fourth quarter. 
• Lakeland Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKFN#NASDAQ">LKFN</a>) is expected to report quarterly earnings at $0.89 per share on revenue of $63.71 million. 
• GrafTech International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) is likely to report quarterly loss at $0.13 per share on revenue of $122.33 million. 
• Avantor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) is projected to report quarterly earnings at $0.23 per share on revenue of $1.61 billion. 
• Oxford Square Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXSQ#NASDAQ">OXSQ</a>) is expected to report quarterly earnings at $0.08 per share on revenue of $9.90 million. 
• Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) is expected to report quarterly earnings at $0.36 per share on revenue of $654.15 million. 
• Preferred Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFBC#NASDAQ">PFBC</a>) is estimated to report quarterly earnings at $2.33 per share on revenue of $70.51 million. 
• Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) is likely to report quarterly earnings at $0.47 per share on revenue of $1.27 billion. 
• Trinet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNET#NYSE">TNET</a>) is projected to report quarterly earnings at $1.61 per share on revenue of $319.36 million. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADXN

AVTR

GNTX

LKFN

OXSQ

PFBC

PHIN

RITM

SAIA

STEL

TNET

VRTS

Earnings Scheduled For April 25, 2025

Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) will release earnings results for the first quarter, before the opening <a href="https://www.benzinga.com/quote/cl/earnings">bell on Friday, April 25.</a>
Analysts expect the New York-based company to report quarterly earnings at 86 cents per share, versus 86 cents per share in the year-ago period. Colgate-Palmolive projects to report quarterly revenue at $4.86 billion, compared to $5.07 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 20, Colgate announced a dividend increase and new $5 billion share repurchase program.
Colgate-Palmolive shares fell 1.3% to close at $92.70 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/cl/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Barclays analyst Lauren Lieberman maintained an Equal-Weight rating and cut the price target from $89 to $86 on April 11, 2025. This analyst has an accuracy rate of 65%.</li>
<li>JP Morgan analyst Andrea Teixeira maintained an Overweight rating and slashed the price target from $99 to $95 on April 11, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Wells Fargo analyst Chris Carey maintained an Underweight rating and raised the price target from $83 to $88 on April 2, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Stifel analyst Mark Astrachan maintained a Hold rating and cut the price target from $95 to $93 on Feb. 3, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Raymond James analyst Olivia Tong reiterated an Outperform rating and slashed the price target from $110 to $105 on Feb. 3, 2025. This analyst has an accuracy rate of 67%.</li>
</ul>
Considering buying CL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="588" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25034822/image-164-1024x588.png" alt="" class="wp-image-888164" style="width:597px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25034822/image-164-1024x588.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25034822/image-164-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25034822/image-164-768x441.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25034822/image-164.png 1092w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44977071/wall-streets-most-accurate-analysts-weigh-in-on-3-materials-stocks-with-over-7-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 7% Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

The CNN Money Fear and Greed index some improvement in market sentiment, while the index remained in the &#8220;Fear&#8221; zone on Thursday.
U.S. stocks settled higher on Thursday, with the Dow Jones index jumping more than 1% during the session to mark the first close above the 40,000 level since April 15.
Shares of Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) all settled higher on Thursday.
Bristol Myers Squibb &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) reported better-than-expected first-quarter results. PepsiCo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) reported mixed first-quarter results and issued FY25 EPS guidance below estimates.
Meanwhile, signs of a potential thaw in the U.S.-China trade conflict emerged, with the White House reportedly considering exceptions for certain Chinese auto parts.
On the economic data front, the Chicago Fed National Activity Index declined to -0.03 in March compared to a reading of +0.24 in February. U.S. initial jobless claims climbed by 6,000 from the previous week to 222,000 during the third week of April. U.S. durable goods orders gained by 9.2% month-over-month to $315.7 billion in March.
Most sectors on the S&amp;P 500 closed on a positive note, with information technology, consumer discretionary and communication services stocks recording biggest gains on Thursday. However, consumer staples stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 487 points to 40,093.40 on Thursday. The S&amp;P 500 jumped 2.03% to 5,484.77, while the Nasdaq Composite surged 2.74% at 17,166.04 during Thursday's session.
Investors are awaiting earnings results from Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>), Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) and Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) today.
At a current reading of 30.9, the index remained in the &#8220;Fear&#8221; zone on Thursday, versus a prior reading of 28.4.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based
&nbsp;on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44977071/wall-streets-most-accurate-analysts-weigh-in-on-3-materials-stocks-with-over-7-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 7% Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

AMZN

NVDA

S&P 500 Rallies 2% On Nvidia, Tesla Gains — But Market Mood Stuck In 'Fear'

Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) is set to give its latest quarterly earnings report on Friday, 2025-04-25. Here's what investors need to know before the announcement.
Analysts estimate that Colgate-Palmolive will report an earnings per share (EPS) of $0.87. 
The announcement from Colgate-Palmolive is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 0.0% drop in the share price the next day.
Here's a look at Colgate-Palmolive's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.89</td>
<td>0.88</td>
<td>0.87</td>
<td>0.76</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.91</td>
<td>0.91</td>
<td>0.91</td>
<td>0.86</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>-4.0%</td>
<td>3.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745506822_0.png" alt="eps graph" />
<h3>Colgate-Palmolive Share Price Analysis</h3>
Shares of Colgate-Palmolive were trading at $93.89 as of April 23. Over the last 52-week period, shares are up 1.8%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on Colgate-Palmolive</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Colgate-Palmolive.
Colgate-Palmolive has received a total of 14 ratings from analysts, with the consensus rating as Outperform. With an average one-year price target of $97.93, the consensus suggests a potential 4.3% upside.
<h3>Understanding Analyst Ratings Among Peers</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Kimberly-Clark, Church &amp; Dwight Co and Clorox, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Kimberly-Clark, with an average 1-year price target of $150.55, suggesting a potential 60.35% upside.</li>
<li>Analysts currently favor an Underperform trajectory for Church &amp; Dwight Co, with an average 1-year price target of $107.83, suggesting a potential 14.85% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Clorox, with an average 1-year price target of $151.75, suggesting a potential 61.63% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
The peer analysis summary provides a snapshot of key metrics for Kimberly-Clark, Church &amp; Dwight Co and Clorox, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Colgate-Palmolive</td>
<td>Outperform</td>
<td>-0.10%</td>
<td>$2.98B</td>
<td>228.44%</td>
</tr>
<tr>
<td>Kimberly-Clark</td>
<td>Outperform</td>
<td>-6.00%</td>
<td>$1.73B</td>
<td>58.42%</td>
</tr>
<tr>
<td>Church &amp; Dwight Co</td>
<td>Underperform</td>
<td>3.53%</td>
<td>$707.90M</td>
<td>4.42%</td>
</tr>
<tr>
<td>Clorox</td>
<td>Neutral</td>
<td>-15.28%</td>
<td>$738M</td>
<td>2031.58%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Colgate-Palmolive ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.
<h3>Get to Know Colgate-Palmolive Better</h3>
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
<h3>Colgate-Palmolive: Delving into Financials</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Challenges: Colgate-Palmolive's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -0.1%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Colgate-Palmolive's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 14.94%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Colgate-Palmolive's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 228.44% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Colgate-Palmolive's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.5% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Colgate-Palmolive's debt-to-equity ratio stands notably higher than the industry average, reaching 40.15. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<a href="https://www.benzinga.com/quote/CL/earnings">To track all earnings releases for Colgate-Palmolive visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Colgate-Palmolive Earnings Preview

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Buy and raises the price target from $105 to $109.

UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $109

WIIM

Colgate-Palmolive shares are trading higher. JP Morgan maintained an Overweight rating on the stock.

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Overweight and lowers the price target from $99 to $95.

Comments

Colgate-Palmolive

Colgate-Palmolive (CL) Opzioni

Colgate-Palmolive (NYSE:CL) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO